F

Fortress Biotech
D

FBIO

1.84000
USD
0.16
(9.52%)
Market Closed
Volume
26,918
EPS
-3
Div Yield
-
P/E
-1
Market Cap
50,793,079
OverviewSignalsIdeasNews
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.945 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    280.01 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.760 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    466.72 USD
    More
News

Title: Fortress Biotech

Sector: Healthcare
Industry: Biotechnology
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq,Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.